Published in Science on September 16, 1994
A novel clade of protistan parasites near the animal-fungal divergence. Proc Natl Acad Sci U S A (1996) 3.34
Phylogenetic analysis of Rhinosporidium seeberi's 18S small-subunit ribosomal DNA groups this pathogen among members of the protoctistan Mesomycetozoa clade. J Clin Microbiol (1999) 3.03
A receptor tyrosine kinase from choanoflagellates: molecular insights into early animal evolution. Proc Natl Acad Sci U S A (2001) 1.73
Report of spores of Henneguya salminicola (Myxozoa) in human stool specimens: possible source of confusion with human spermatozoa. J Clin Microbiol (1997) 1.67
Genomic insights into the evolutionary origin of Myxozoa within Cnidaria. Proc Natl Acad Sci U S A (2015) 1.60
The homeodomain complement of the ctenophore Mnemiopsis leidyi suggests that Ctenophora and Porifera diverged prior to the ParaHoxozoa. Evodevo (2010) 1.48
History of myxozoan character evolution on the basis of rDNA and EF-2 data. BMC Evol Biol (2010) 1.07
Evidence against the exon theory of genes derived from the triose-phosphate isomerase gene. Proc Natl Acad Sci U S A (1995) 1.06
Myxobolus turpisrotundus (Myxosporea: Bivalvulida) spores with caudal appendages: investigating the validity of the genus Henneguya with morphological and molecular evidence. Parasitol Res (2010) 1.01
Two new species of Myxobolus (Myxozoa: Myxosporea: Bivalvulida) infecting an Indian major carp in Ropar and Kanjali wetlands (Punjab). J Parasit Dis (2011) 0.97
A novel minicollagen gene links cnidarians and myxozoans. Proc Biol Sci (2010) 0.95
Incidental finding of Myxobolus spores (protozoa: myxozoa) in stool samples from patients with gastrointestinal symptoms. J Clin Microbiol (1998) 0.93
Agent of whirling disease meets orphan worm: phylogenomic analyses firmly place Myxozoa in Cnidaria. PLoS One (2013) 0.91
Biology and mucosal immunity to myxozoans. Dev Comp Immunol (2013) 0.85
Myxobolus sp., another opportunistic parasite in immunosuppressed patients? J Clin Microbiol (2001) 0.83
Cell formation by myxozoan species is not explained by dogma. Proc Biol Sci (2010) 0.83
The genome of the myxosporean Thelohanellus kitauei shows adaptations to nutrient acquisition within its fish host. Genome Biol Evol (2014) 0.82
Henneguya sp. in yellowfin goby Acanthogobius flavimanus from the San Francisco Estuary. Springerplus (2013) 0.82
Supplementary studies on Henneguya doneci Schulman, 1962 (Myxozoa: Myxosporea) infecting the gill filaments of Carassius auratus gibelio (Bloch) in China: histologic, ultrastructural, and molecular data. Parasitol Res (2011) 0.79
The Mitochondrial Genomes of a Myxozoan Genus Kudoa Are Extremely Divergent in Metazoa. PLoS One (2015) 0.78
In silico hybridization enables transcriptomic illumination of the nature and evolution of Myxozoa. BMC Genomics (2015) 0.77
Biodiversity Meets Neuroscience: From the Sequencing Ship (Ship-Seq) to Deciphering Parallel Evolution of Neural Systems in Omic's Era. Integr Comp Biol (2015) 0.76
Ultrastructural studies on the development of Enteromyxum scophthalmi (Myxozoa), an enteric parasite of turbot (Scophthalmus maximus L.). Parasitol Res (2003) 0.76
The phylogenetic position of Myxoboluscarnaticus (Myxozoa, Myxosporea, Bivalvulida) infecting gill lamellae of Cirrhinus mrigala (Hamilton, 1822) based on 18S rRNA sequence analysis. Mol Biol Res Commun (2015) 0.75
Molecular phylogeny of Myxobolus orissae (Myxosporea: Myxobolidae) infecting the gill lamellae of mrigal carp Cirrhinus mrigala (Actinopterygii: Cyprinidae). Mol Biol Res Commun (2015) 0.75
Molecular and morphological descriptions of Ceratomyxa collarae n. sp. and Ceratomyxa leucosternoni n. sp. from marine ornamental fishes of Indian waters. Parasitol Res (2016) 0.75
A gene expression database for the molecular pharmacology of cancer. Nat Genet (2000) 13.31
MedMiner: an Internet text-mining tool for biomedical information, with application to gene expression profiling. Biotechniques (1999) 5.56
EQUIL2: a BASIC computer program for the calculation of urinary saturation. J Urol (1985) 2.71
Cardio-selective beta-blockade. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 2.33
Acquired hyperoxaluria, nephrolithiasis, and intestinal disease. Description of a syndrome. N Engl J Med (1972) 2.21
Treatment of primary hyperparathyroidism. Am J Med (1974) 1.98
Primary hyperparathyroidism: a prospective clinical study. Am J Med (1971) 1.93
Biochemistry and physiology of taurine and taurine derivatives. Physiol Rev (1968) 1.88
Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation (1998) 1.74
Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancer. J Clin Invest (1971) 1.68
The recognition and isolation from urine and serum of a peptide inhibitor to calcification. Johns Hopkins Med J (1967) 1.54
Cytotoxic efficiency and effect on tumour growth of heterospecific antilymphocytic and antitumour sera. Nature (1970) 1.51
Comparative effect of two strains of C. parvum on phagocytic activity and tumour growth. Nature (1968) 1.47
L-glyceric aciduria. A new genetic variant of primary hyperoxaluria. N Engl J Med (1968) 1.41
beta-Adrenergic blocking agents. 16. 1-(Acylaminomethyl-, ureidomethyl-, and ureidoethylphenoxy)-3-amino-2-propanols. J Med Chem (1977) 1.39
The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis (1988) 1.36
Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med (1994) 1.36
Psyllid endosymbionts exhibit patterns of co-speciation with hosts and destabilizing substitutions in ribosomal RNA. Insect Mol Biol (2001) 1.35
Disorders of oxalate metabolism. Am J Med (1968) 1.34
Effects of freezing on marrow stem cell suspensions: interactions of cooling and warming rates in the presence of PVP, sucrose, or glycerol. Cryobiology (1970) 1.30
Government and academic health science centers. West J Med (1993) 1.26
Intussusception: analysis of 98 cases. Br J Surg (1981) 1.25
Phylogenetic characterization and molecular evolution of bacterial endosymbionts in psyllids (Hemiptera: Sternorrhyncha). Mol Biol Evol (1998) 1.25
Clinical features and management of cystinuria. Mayo Clin Proc (1977) 1.25
The tryptophan biosynthetic pathway of aphid endosymbionts (Buchnera): genetics and evolution of plasmid-associated anthranilate synthase (trpEG) within the aphididae. J Mol Evol (1996) 1.22
The in vitro transcription units of bacteriophage phiX174. II. In vitro initiation sites of phiX174 transcription. J Mol Biol (1976) 1.19
Hydrochlorothiazide effects on serum calcim and immunoreactive parathyroid hormone concentrations. Studies in normal subjects. Ann Intern Med (1972) 1.18
Extranuclear estrogen-regulated destabilization of Xenopus laevis serum albumin mRNA. Mol Endocrinol (1989) 1.15
The stone clinic effect in patients with idiopathic calcium urolithiasis. J Urol (1983) 1.14
Phenotypic expression of primary hyperoxaluria: comparative features of types I and II. Kidney Int (2001) 1.13
Nucleotide sequences of the 5' termini of phi X174 mRNAs synthesized in vitro. Nucleic Acids Res (1974) 1.12
Thyroid cancer in pregnancy. Int J Gynaecol Obstet (2005) 1.10
Endometriosis-related malignancies. Int J Gynecol Cancer (2003) 1.09
Progress with enhancing veterinary surveillance in the United Kingdom. Vet Rec (2007) 1.07
A urinary peptide with extraordinary inhibitory powers against biological "calcification" (deposition of hydroxyapatite crystals). Trans Assoc Am Physicians (1966) 1.07
Anaerobic bacteria in the urinary tract. Mayo Clin Proc (1972) 1.06
FACTORS AFFECTING THE APPEARANCE AND PERSISTENCE OF VISIBLE CUTANEOUS REACTIVE HYPEREMIA IN MAN. J Clin Invest (1948) 1.05
Transport of citrate across renal brush border membrane: effects of dietary acid and alkali loading. Am J Physiol (1985) 1.02
Laxative abuse as a cause for ammonium urate renal calculi. J Urol (1990) 1.01
Treatment of primary hyperoxaluria. Mod Treat (1967) 1.01
The in vitro transcription units of bacteriophage phiX174. III. Initiation with specific 5' end oligonucleotides of in vitro phiX174 RNA. J Mol Biol (1976) 1.00
Potentiation of butylated hydroxytoluene-induced acute lung damage by oxygen. Cell kinetics and collagen metabolism. Am Rev Respir Dis (1983) 0.99
Deficiency of 2-oxo-glutarate: glyoxylate carboligase activity in primary hyperoxaluria. Proc Natl Acad Sci U S A (1967) 0.98
The metabolic error in primary hyperoxaluria. Arch Dis Child (1965) 0.98
Modified nucleosides in urine: selective removal and analysis. Clin Chem (1976) 0.97
Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors. Invest Urol (1975) 0.96
Alan Gregg memorial lecture. Medical education for the 21st century. J Med Educ (1985) 0.96
Epitaxial relationships in urolithiasis: the brushite-whewellite system. Clin Sci Mol Med (1977) 0.96
Goniometric reliability for a child with spastic quadriplegia. J Pediatr Orthop (1985) 0.96
T-type and L-type calcium currents in freshly dispersed human uterine smooth muscle cells. Am J Obstet Gynecol (1993) 0.96
The in vitro transcription units of bacteriophage phiX174. I. Characterization of synthetic parameters and measurement of transcript molecular weights. J Mol Biol (1976) 0.95
Physiological basis of differential strontium accumulation in two barley genotypes. Plant Physiol (1966) 0.95
The determination of pentosans in the analysis of woods: The gravimetric determination of furfuraldehyde. Biochem J (1937) 0.95
Symposium on stones. Introduction. Books in the running brooks, sermons in stone. Am J Med (1968) 0.95
Hydroxyprolinemia. 3. The origin of free hydroxyproline in hydroxyprolinemia. Collagen turnover. Evidence for biosynthetic pathway in man. Biochim Biophys Acta (1968) 0.94
Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria. J Clin Endocrinol Metab (1980) 0.94
Estrogen regulation of Xenopus laevis gamma-fibrinogen gene expression. Biochemistry (1990) 0.94
Soft-tissue profile change associated with surgical correction of the prognathic mandible. Am J Orthod (1974) 0.94
Beta-adrenergic blocking agents. II. Propranolol and related 3-amino-1-naphthoxy-2-propanols. J Med Chem (1968) 0.93
Combined hepatic and renal transplantation in primary hyperoxaluria type I: clinical report of nine cases. Am J Med (1991) 0.93
Preparation and composition of alveolar extracellular matrix and incorporated basement membrane. Lung (1981) 0.93
Acquired hyperoxaluria and intestinal disease. Evidence that bile acid glycine is not a precursor of oxalate. Mayo Clin Proc (1973) 0.93
Oxalate absorption and postprandial urine supersaturation in an experimental human model of absorptive hypercalciuria. Clin Sci (Lond) (1984) 0.92
Chemical softness and acute metal toxicity in mice and Drosophila. Toxicol Appl Pharmacol (1982) 0.92
Percutaneous lithotripsy. J Urol (1983) 0.91
Suture entrapment and secondary ureteral obstruction. Am J Obstet Gynecol (1991) 0.91
Condylomata acuminata. Roles of different techniques of laser vaporization. J Reprod Med (1993) 0.91
Diagnosis of primary hyperparathyroidism. Surg Clin North Am (1977) 0.91
Epitaxial relationships in urolithiasis: the calcium oxalate monohydrate-hydroxyapatite system. Clin Sci Mol Med (1975) 0.90
Long-term prognosis in primary hyperoxaluria type II (L-glyceric aciduria). Am J Kidney Dis (1994) 0.90
Chemoradiation for primary invasive squamous carcinoma of the vagina. Int J Gynecol Cancer (2004) 0.90
Urinary citrate excretion in normal persons and patients with idiopathic calcium urolithiasis. J Lab Clin Med (1985) 0.89
Clinical expression and long-term outcomes of primary hyperoxaluria types 1 and 2. J Nephrol (1998) 0.87
Phosphorus excretion in tumoral calcinosis: response to parathyroid hormone and acetazolamide. J Clin Endocrinol Metab (1980) 0.87
The renal clearance of oxalate in normal subjects and patients with primary hyperoxaluria. Clin Sci (1971) 0.87
Cloning and characterization of bys1, a temperature-dependent cDNA specific to the yeast phase of the pathogenic dimorphic fungus Blastomyces dermatitidis. Infect Immun (1994) 0.87
Altered morphology in cultured rat intestinal epithelial IEC-6 cells is associated with alkaline phosphatase expression. Tissue Cell (2003) 0.86
Biomedical research and national policy. J Clin Invest (1970) 0.85
The epitaxially induced crystal growth of calcium oxalate by crystalline uric acid. Invest Urol (1976) 0.85
Renal brush border membrane adaptation to phosphorus deprivation: effects of fasting versus low-phosphorus diet. Kidney Int (1980) 0.84
Beta-adrenergic blocking agents. I. Pronethalol and related N-alkyl and N-aralkyl derivatives of 2-amino-1-(2-naphythyl)ethanol. J Med Chem (1968) 0.84
Triamterene urolithiasis: solubility, pk, effect on crystal formation, and matrix binding of triamterene and its metabolites. J Lab Clin Med (1982) 0.84
Study of the selective cytotoxic properties of cationic, lipophilic mitochondrial-specific compounds in gynecologic malignancies. Gynecol Oncol (1990) 0.83
Inhibitors of crystal growth of hydroxyapatite: a constant composition approach. J Urol (1985) 0.83
Growth of calcium oxalate crystals. I. A model for urinary stone growth. Invest Urol (1975) 0.83
Pathogenesis of renal stones. Miner Electrolyte Metab (1987) 0.83
Xenopus laevis serum albumin: sequence of the complementary deoxyribonucleic acids encoding the 68- and 74-kilodalton peptides and the regulation of albumin gene expression by thyroid hormone during development. Mol Endocrinol (1989) 0.82
Effect of small doses of syngeneic bone marrow on the 30- and 90-day LD50 of X-irradiated mice. Radiat Res (1969) 0.82
Metabolic and clinical disturbances in patients with calcium urolithiasis. Scand J Urol Nephrol Suppl (1980) 0.82
Role of ultrasound in medical management of patients with renal stone disease. Urol Radiol (1992) 0.82
Long-term followup in patients with cystine urinary calculi treated by percutaneous ultrasonic lithotripsy. J Urol (1988) 0.81
New treatment for struvite urinary stones. N Engl J Med (1984) 0.81
Urinary excretion of isethionic acid in man. Nature (1967) 0.81
Pyrimidine metabolism in man. N Engl J Med (1973) 0.81
Mesenteric angiofollicular lymph node hyperplasia (lymphoid hamartoma) with nephroitc syndrome. Mayo Clin Proc (1975) 0.81
Binding of benzo [a]pyrene to epidermal DNA and RNA as detected by synchronous luminescence spectrometry at 77 K. J Biochem Biophys Methods (1980) 0.81
Symposium on renal lithiasis. Medical evaluation of urolithiasis. Etiologic aspects and diagnostic evaluation. Urol Clin North Am (1974) 0.81
Hyperoxaluria in L-glyceric aciduria: possible pathogenic mechanism. Science (1971) 0.81
EFFECTS OF HYPOXIA AND HYPERCAPNIA ON PERCEPTION OF THERMAL CUTANEOUS PAIN. J Clin Invest (1948) 0.81